Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis

about

Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B

P2860

Q58701149-72824B08-6249-4340-9557-998600E80D8E

P2860

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis

Item

http://www.wikidata.org/entity/Q57952724

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Comparative efficacy, toxicity ...... murine cutaneous leishmaniasis

@en

Comparative efficacy, toxicity ...... murine cutaneous leishmaniasis

@nl

type

Item

label

Comparative efficacy, toxicity ...... murine cutaneous leishmaniasis

@en

Comparative efficacy, toxicity ...... murine cutaneous leishmaniasis

@nl

prefLabel

Comparative efficacy, toxicity ...... murine cutaneous leishmaniasis

@en

Comparative efficacy, toxicity ...... murine cutaneous leishmaniasis

@nl

P1476

Comparative efficacy, toxicity ...... murine cutaneous leishmaniasis

@en

P2093

Andy Harris

http://www.w3.org/2001/XMLSchema#string

Gert-Jan Wijnant

http://www.w3.org/2001/XMLSchema#string

Katrien Van Bocxlaer

http://www.w3.org/2001/XMLSchema#string

Mo Alavijeh

http://www.w3.org/2001/XMLSchema#string

Rita Silva-Pedrosa

http://www.w3.org/2001/XMLSchema#string

Simon L Croft

http://www.w3.org/2001/XMLSchema#string

Sudaxshina Murdan

http://www.w3.org/2001/XMLSchema#string

Vanessa Yardley

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

A curative immune profile one week after treatment of Indian kala-azar patients predicts success with a short-course liposomal amphotericin B therapy

Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.

Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis

Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate

Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis

Investigating the optimal size of anticancer nanomedicine.

Overview of the lipid formulations of amphotericin B.

Post-kala-azar dermal leishmaniasis.

P304

223-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJPDDR.2018.04.001

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Antunes

Isabel L. Mauricio

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29673889

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

parasitology

infectious disease

P932

6039306

http://www.w3.org/2001/XMLSchema#string

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis

about

P2860

P2860

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932